(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate, 95.0%, 250mg

2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

4-Chloro-2-methylphenol, 99.0%, 25g

(5-Chloro-1,3-dimethyl-1h-pyrazol-4-yl)methanol, 95%, 100mg

N-(tert-butoxycarbonyl)-N-isopropylphenylalanine, 98%, 100mg

N-(2-IODOPHENYL)ACRYLAMIDE, 95.0%, 250mg

Dimethyl-1,2-oxazol-3-ol, 250mg

Naftifine Hydrochloride>98.0%(HPLC)5g

2-Quinolinecarboxylic acid, 98.0%, 10g

Methyl 2-(3-bromophenyl)-2-methylpropanoate, 95.0%, 25g

Plan phase PLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.00 mm

Accessories protective seals, 10 Piece(s)

5-Iodoquinoline, 98%, 1g